A senator has stated that the US lacks a backup plan in case foreign generic drugmakers cease production. There are proposals for changes to generic drug oversight and discussions about the need to reshore essential medicine production. The issue of generic drugs has sparked concern and discussion, with some outlets questioning potential problems with the current system and others focusing on prescription drug costs.